Spasibo Enterprise Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.65 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.73 Cr
- Satisfied Charges ₹ 2.50 Cr
- Revenue Growth 60.23%
- Profit Growth 61.37%
- Ebitda 55.06%
- Net Worth 29.39%
- Total Assets 58.06%
About Spasibo Enterprise
Spasibo Enterprise Private Limited (SEPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 November 2018 (Six years and two months 30 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.65 M.
The company currently has active open charges totaling ₹3.73 Cr. The company has closed loans amounting to ₹2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anirban Chatterjee and Sangeeta Das serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909WB2018PTC228980
- Company No.
228980
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Nov 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Spasibo Enterprise?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anirban Chatterjee  | Director | 27-Nov-2018 | Current |
| Sangeeta Das | Director | 27-Nov-2018 | Current |
Financial Performance of Spasibo Enterprise.
Spasibo Enterprise Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 60.23% increase. The company also saw a substantial improvement in profitability, with a 61.37% increase in profit. The company's net worth Soared by an impressive increase of 29.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spasibo Enterprise?
Unlock access to Spasibo Enterprise's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Prospect Pharmaceuticals Private LimitedAnirban Chatterjee and Sangeeta Das are mutual person
Charges (Loans)
₹37.26 M
₹25.00 M
Charges Breakdown by Lending Institutions
- Bank Of India : 3.73 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jul 2023 | Bank Of India | ₹3.73 Cr | Open |
| 04 Sep 2019 | Others | ₹2.50 Cr | Satisfied |
How Many Employees Work at Spasibo Enterprise?
Spasibo Enterprise has a workforce of 15 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spasibo Enterprise, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spasibo Enterprise's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
